On December 23, 2020, Carlo Campiciano resigned as the Chief Financial Officer of Propanc Biopharma, Inc., effective on that date. There was no disagreement or dispute with the Company concerning his resignation. In connection with Mr. Campiciano's resignation as Chief Financial Officer, he relinquished his role as the Company's 'Principal Financial and Accounting Officer' for Securities and Exchange Commission reporting purposes.